SUMMARY Early revascularization following myocardial infarction (MI) is reported to have a high risk of extension of and hemorrhage into infarction with resulting high mortality and morbidity. To evaluate this issue, 80 post-MI patients (aged 32-74 years) with unstable angina pectoris resistant to maximal medical therapy were reviewed. All patients underwent early uncomplicated angiography and subsequent revascularization; 55 (69%) were less than 10 days post-MI, and 25 (31%) were 10-30 days post-MI. Intraaortic balloon pumping was required in 72% for relief of intractable angina or hemodynamic instability. Of the 80 patients, 19% had single vessel disease (VD), 31% double VD, and 50% triple VD. The mortality rate from coronary bypass surgery was 7/80 (8.8%), with four cardiac and three noncardiac deaths. Two patients suffered a perioperative MI (2.5%). At a mean follow-up period of 33 months, there had been only one late death and one recurrent nonfatal MI; 96% of the patients had no significant angina. In patients with continuing ischemia immediately after MI, myocardial revascularization can be safely performed without further injury to the myocardium, and with excellent long-term results.
PERSISTENT OR RECURRENT CHEST PAIN following acute myocardial infarction (MI) is a manifestation of severe myocardial ischemia and therefore requires urgent therapy to avoid extension of infarction with the attendant increased mortality and morbidity. Patients in whom ischemia is not controlled on a maximal program of medical therapy have been considered candidates for urgent myocardial revascularization to preserve myocardial function and to diminish the mortality and morbidity of ongoing ischemia. Early reports of acute revascularization following MI indicated a high risk of extension of and hemorrhage into infarction, with resulting high mortality rates;'-' more recent studies, however, with improved methods for the intraoperative protection of the ischemic myocardium, have been far more encouraging.4-10 To evaluate this issue, we have reviewed our experience with early revascularization in patients with intractable ischemia during the recovery period from acute MI.
Materials and Methods We studied 80 patients with intractable angina after acute MI; there were 69 men and 11 women ranging in age from 32 to 74 years (average, 52 years) ( fig. 1 ). These patients had recurrent ischemic attacks at rest while recovering from an acute MI documented by history, enzymes and electrocardiographic changes. Fifty-one patients had anterior infarctions, and 29 inferior. Transmural infarction was documented by electrocardiographic evidence of new Q waves in 54 patients, and subendocardial infarction in the remaining 26 patients; 55 patients were less than 10 days post-MI, and 25 patients were 10-30 days post-MI.
All patients were carefully monitored in the intensive care area, and medical therapy was gradually increased to a maximal regimen. Propranolol was increased to reduce resting heart rate below 60 beats/min without myocardial depression. Nitrate therapy in the form of sublingual nitroglycerin, isosor- bide dinitrate, nitroglycerin ointment, and intravenous nitroglycerin was increased to a systolic blood pressure below 100 mm Hg. Recurrent pain with the above regimen necessitated intraaortic balloon pump (IABP) insertion in 58 patients (72.5%). Of the patients less than 10 days post-MI, 82% (45/55) required IABP support compared to 52% (13/25) of the patients 10-30 days post-MI. All patients underwent selective coronary arteriography and left ventriculography by the Sones technique, and cardiac catheterization was followed within 72 hours by coronary artery bypass surgery.
Results
There were 15 patients (19%) with single-vessel disease (the left anterior descending artery in all cases), 25 (31%) with two-vessel disease, and 40 (50%) with three-vessel disease ( fig. 2 ). The left anterior descending coronary artery was significantly diseased (>70% obstruction) in all patients. The right coronary artery was involved in 58 patients (72.5%), while the circumflex distribution had significant disease in 40 patients (50%).
All patients were considered operable and underwent aortocoronary saphenous vein bypass grafting. Careful consideration was given to protecting the myocardium to avoid active ischemia during the perioperative period. Precise hemodynamic and electrocardiographic monitoring was carried out. Standard lead II and V4 of the ECG were monitored continuously, and pulmonary capillary wedge pressures and thermodilution cardiac outputs routinely measured intraoperatively. Elevation of wedge pressure and/or ECG changes indicative of ischemia in the pre-bypass period were aggressively treated with intravenous nitroglycerin, and tachyarrhythmias managed by judicious small doses of intravenous propranolol. In those patients with an IABP in place, mechanical support was continued throughout the entire perioperative period. While the patient was on cardiopulmonary bypass, mean arterial perfusion pressure was maintained at a level greater than 70 mm Hg. Both topical and systemic hypothermia (28°C) were employed, and the left ventricle was decompressed by a left ventricular vent. Vessels were individually isolated and bypassed whenever feasible, and global ischemia was minimized.
A single vein bypass was performed in 13 patients (16%), a double bypass in 39 (49%), a triple bypass in 26 (32.5%), and a quadruple bypass procedure in 2 patients (2.5%) ( fig. 3 ).
There were seven perioperative deaths (8.8%) in patients ranging from 47 to 70 years of age. All deaths occurred in patients with anterior infarctions: five transmural, and two subendocardial. Two of the seven patients had sustained a previous MI. Five had triplevessel and two had double-vessel disease. Four patients underwent operation less than 10 days post-MI, and the remaining three were operated on between 22 and 30 days post-MI. Six of the seven patients were felt to require IABP, but the balloon could only be inserted in four of the six. The seventh patient was stable on intravenous nitroglycerin. Only one patient of the six who were felt to require the IABP had complete relief of pain, the other five patients had recurrent ischemia at the time of opera-EXTENT OF CORONARY DISEASE tion. Four of these five patients had myocardial deaths. One patient was noted to have patchy ischemia and depressed contractility in the operating room prior to bypass and after revascularization was unable to be separated from cardiopulmonary support. Two other patients fibrillated in the intensive care unit within 24 hours of operation and resuscitation was unsuccessful. At autopsy, bypass grafts were patent but there was evidence of acute myocardial injury. The fourth was a patient with a significant left main lesion and diffuse three-vessel disease who experienced cardiac arrest on the 10th postoperative day, most likely secondary to an acute inferior infarction. The remaining three patients died of noncardiac causes. A 70-year-old man with extensive atherosclerosis sustained an aortic dissection soon after institution of cardiopulmonary bypass. Although the lesion was immediately repaired, the patient died several days later of further extension of the dissection. The second and third patients both had uneventful double-bypass graft procedures, but one sustained a fatal embolic vascular accident postoperatively, and the other developed a drug-induced toxic epidermal necrolysis 10 days after operation and eventually succumbed to sepsis due to this uncommon entity (table 1) .
There were 73 patients who survived the perioperative period. Only two of these patients showed new Q waves in the postoperative ECG (2.5%). Their operations were 7 and 27 days after the initial MI.
Late Follow-Up We have followed 73 patients for 6 months to 6½/2 years, for an average of 33.2 months. There has been only one late death. The patient, a 49-year-old man with diffuse distal disease and continued angina after revascularization, sustained a fatal MI 14 months after operation. Only one other patient has sustained a symptomatic MI, which occurred I month after operation.
Therefore, 72 patients were available for late evaluation: 57 (79%) were free of angina, 12 (17%) had rare or mild angina that did not interfere with normal activity, two (3%) had significant angina controlled on a medical program, and only one (1%), who had sustained a late MI, was disabled by angina ( fig. 4) .
At late follow-up, 36 patients (50%) were working full time, three (4%) were working part-time, and four (6%) were fully active as housewives. Ten patients (14%) were over 65 years old and retired, and the remaining 19 (26%) considered themselves occupationally disabled ( fig. 5 ).
Fifty-one patients felt no limitation on their activities. Of the remaining 21 patients, eight were limited from full activity by angina, mild in seven and severe in one. Seven additional patients felt limited by dyspnea or fatigue, and the six remaining patients were limited by noncardiac disease.
Discussion
The morbidity and mortality of MI have been well documented. In a recent study at our institution, the early mortality of transmural infarction was 29% and that of subendocardial infarction 14%. Long-term follow-up indicated a very significant morbidity and mortality after MI, with a 13% late mortality for transmural infarction and a 26% mortality for subendocardial infarction over a 3-year period. Subsequent MI occurred in 34% of the subendocardial group and 10% of the transmural group." These statistics have been confirmed by others. Levy et al.'2 noted recurrent MI in 26% of the subendocardial group and 12% of the transmural group, with a high percentage of patients having significant angina (subendocardial 61%, transmural 35%); these data are supported by the observations of Madigan et al.13 in patients after subendocardial infarction (unstable angina in 46%, reinfarction in 21%). Stenson et al.'4 have identified those post-MI patients with persistent or recurrent pain, especially those with ST-segment elevation, as a group with a particularly high mortality.
The major cause of death after MI is attributed to left ventricular power failure, and this is a major cause of late disability, as well, in those who survive. The extent of necrosis, therefore, is a major determinant of the prognosis in patients with acute MI. Early revascularization becomes an attractive concept in an attempt to salvage ischemic myocardium and reduce potential infarct size, thus reducing patient morbidity and mortality. Such an approach appears particularly relevant in patients after subendocardial infarction, which appears to be a more unstable ischemic event with a very significant risk of subsequent further infarction and mortality. In many centers, early clinical experience with acute revascularization for an evolving MI indicated a rather high operative mortality rate.' More recent studies from several institutions have demonstrated VOCATIONAL ACTIVITY AFTER REVASCULARIZATION Part-Time In all the studies above, limited late follow-up has shown gratifying long-term results, with low morbidity and mortality.
The group of patients presented here are those patients with ongoing myocardial ischemia despite aggressive maximal medical therapy. With a combination of pharmacologic and mechanical support, this group has successfully undergone cardiac catheterization and subsequent revascularization, with a low mortality rate and minimal exacerbation of myocardial injury. All deaths occurred in patients after anterior infarction, a group with a higher incidence of congestive failure than those with inferior damage. All cardiac-related mortality also occurred in patients with ongoing ischemia in spite of all therapeutic modalities, further indication of the need for aggressive treatment of recurrent or ongoing ischemia in patients after acute MI. Late postoperative results are extremely encouraging, particularly when compared to the natural history of MI. There has been only one late death in our series and one recurrent nonfatal MI in a mean follow-up period of almost 3 years. The great majority of patients are active and free of significant angina.
We conclude that early revascularization for intractable ischemia after acute MI can be performed safely without further injury to the myocardium and with excellent long-term results. stable angina pectoris. Long-term follow up of patients undergoing intra-aortic balloon counterpulsation and operation.
Am J Cardiol (in press) 8. Levine FH, Gold HK, Leinbach Aortocoronary Bypass Surgery SUMMARY Follow-up of 748 consecutive patients who underwent aortocoronary artery bypass grafts was obtained for 5 to 94 months (average, 59 months). Operative mortality of 2.5% did not vary with number of vessels bypassed. There was a linear 3.5% annual recurrence rate of angina, and average annual late infarction rate of 1.4%. The cumulative survival rates did not differ for the number of grafts performed or for men and women, but did differ for left main coronary stenosis and impaired ejection fractions. The late cumulative survival rates for the entire group approached those of the general U.S. population.
AORTOCORONARY BYPASS SURGERY has become a frequently employed therapeutic intervention in the management of coronary heart disease, although controversy still exists concerning its indications and results.' St. Luke's Hospital Center has had a large surgical experience with careful follow-up over the past 7 years. Results of this experience with 748 consecutive patients are presented herein.
Material and Methods
During the period June 1, 1970 until December 31, 1973, 748 consecutive patients had coronary bypass graft procedures at St. Luke's Hospital Center and constitute the study group. Patients undergoing additional cardiac surgery such as aneurysm resection or valve surgery were not included. No patient was excluded for any other reason.
